VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Abbott Laboratories vs Ferrari N.V.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Abbott Laboratories
ABT · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Abbott Laboratories's moat claims, evidence, and risks.
View ABT analysisFerrari N.V.
RACE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Ferrari N.V.'s moat claims, evidence, and risks.
View RACE analysisComparison highlights
- Moat score gap: Ferrari N.V. leads (81 / 100 vs 64 / 100 for Abbott Laboratories).
- Segment focus: Abbott Laboratories has 7 segments (26.7% in Cardiovascular & Electrophysiology Devices); Ferrari N.V. has 3 segments (85.8% in Cars and spare parts).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Abbott Laboratories has 10 moat types across 3 domains; Ferrari N.V. has 5 across 3.
Primary market context
Abbott Laboratories
Cardiovascular & Electrophysiology Devices
Cardiovascular, electrophysiology, rhythm management, structural heart and heart failure devices
Global
Hospitals, ambulatory surgery centers, cardiologists/electrophysiologists
Implantable device manufacturer
26.7%
Ferrari N.V.
Cars and spare parts
Luxury performance cars and OEM spare parts/after-sales
Global
High-net-worth individuals and collectors; sales and service via authorized dealers
OEM / brand owner with selective dealer distribution
85.8%
Side-by-side metrics
Moat coverage
Shared moat types
Abbott Laboratories strengths
Ferrari N.V. strengths
Segment mix
Abbott Laboratories segments
Full profile >Established Pharmaceutical Products
Competitive
Diagnostic Products
Oligopoly
Pediatric Nutrition
Oligopoly
Adult Nutrition
Oligopoly
Diabetes Care (CGM & glucose monitoring)
Duopoly
Cardiovascular & Electrophysiology Devices
Oligopoly
Neuromodulation Devices
Oligopoly
Ferrari N.V. segments
Full profile >Cars and spare parts
Oligopoly
Sponsorship, commercial and brand
Competitive
Other
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.